Strengthening the Pharmaceutical System in the Kingdom of Saudi Arabia : Towards a Medicine Policy to Support Vision 2030

This document presents the major issues that were discussed in the process of working towards the development of a new medicines policy in Saudi Arabia, examining current national practice in light of international practices and experiences. The document is designed to foster discussion and help inform the development of a new national medicine policy. A detailed accounting of the evidence informing policy choices to be highlighted in an updated medicine policy are presented in Part I of this discussion paper; a proposed new National Medicine Policy itself is presented in Part ll. A new Medicine policy, once finalized and approved, will need to be implemented in a highly dynamic environment and must therefore allow for flexibility. It will need to be followed by the implementation of regulations, closely monitored, and adapted as necessary over time.

Bibliographic Details

Main Authors:	Alghaith, Taghred, Almoteiry, Khalid, Alamri, Adwa, Alluhidan, Mohammed, Alharf, Adel, Al-Hammad, Bander, Aliafali, Ibrahim, Seiter, Andreas, Pisani, Elizabeth, Herbst, Christopher H., El-Saharty, Sameh, Alazemi, Nahar
Format:	Working Paper biblioteca
Language:	English
Published:	World Bank, Washington, DC 2020
Subjects:	PHARMACEUTICAL SYSTEM, MEDICINE POLICY, ACCESS TO HEALTH CARE, MEDICINE PRICING, PHARMACEUTICAL INDUSTRY,
Online Access:	http://documents.worldbank.org/curated/en/305991624017831749/Strengthening-the-Pharmaceutical-System-in-the-Kingdom-of-Saudi-Arabia-Towards-a-Medicine-Policy-to-Support-Vision-2030 http://hdl.handle.net/10986/35846
Tags:	Add Tag No Tags, Be the first to tag this record!